Patent details

Basic Information

Publication number:

LUC00189

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP047539259

Legal Status:

Active

Application number:

LUC00189

First applicant's nationality:

Procedural language:

French

Marketing Authorization

1

Marketing Authorization Number:

202009252 à 202009257

Marketing Authorization Type:

Marketing Authorization Date:

01/09/2020

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Luxembourg (LU)

2

Marketing Authorization Number:

PL08081/0050-52

Marketing Authorization Type:

Marketing Authorization Date:

01/02/2013

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

United Kingdom (GB)

Dates

Filing date:

08/12/2020

First Marketing Authorization date:

01/02/2013

Grant date:

14/12/2021

Activation date:

01/06/2024

Publication date:

11/12/2020

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

01/02/2028

SPC Extension Expiration:

01/02/2028

Rejection date:

Withdrawal date:

Owner

From:

03/05/2023

 

 

Name:

TAKEDA PHARMACEUTICALS U.S.A. INC.

Address:

95 Hayden Avenue,, Lexington,, MA 02421, United States (US)

History of Owners

From:

08/12/2020

To:

03/05/2023

Name:

Takeda Pharmaceutical Company Limited

Address:

1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, Japan (JP)

Agent

Name:

Dennemeyer & Associates S.A.

From:

08/12/2020

Address:

55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)

To:

Publication

Bulletin

1

Bulletin Heading:

CO

Bulletin edition number:

2023/07

Publication date:

06/06/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:

SPC1

Bulletin edition number:

2021/01

Publication date:

05/01/2021

Description:

Section C : Published requests for Supplementary Protection Certificates – I1 publication

3

Bulletin Heading:

SPC2

Bulletin edition number:

2022/01

Publication date:

03/01/2022

Description:

Section D : Granted supplementary protection certificates – I2 publication

4

Bulletin Heading:

SPC3

Bulletin edition number:

2024/09

Publication date:

11/07/2024

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20230000210A

Date Registered:

03/05/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Dennemeyer & Associates S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

TAKEDA PHARMACEUTICALS U.S.A. INC.

Address:

95 Hayden Avenue,, Lexington,, MA 02421, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

23

Annual Fee Amount:

430 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/05/2025

Last Annual Fee Paid Number:

22

Last Annual Fee Paid Amount:

420 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
08/12/2020	MA publication	5
03/05/2023	Request For Change	8
03/05/2023	Outgoing Correspondence	1
08/12/2020	MA publication	5
14/12/2021	Publication	1
08/12/2020	Marketing authorization	5
14/12/2021	Outgoing Correspondence	1
08/12/2020	Marketing authorization	5
08/12/2020	MA publication	59
08/12/2020	Marketing authorization	5
08/12/2020	Application Form	4
11/12/2020	Outgoing Correspondence	1
08/12/2020	Marketing authorization	5
11/12/2020	Publication	1
14/12/2021	Certificate	1